News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
690,555 Results
Type
Article (40121)
Company Profile (284)
Press Release (650150)
Section
Business (206286)
Career Advice (1996)
Deals (35759)
Drug Delivery (83)
Drug Development (80995)
Employer Resources (168)
FDA (16272)
Job Trends (14916)
News (347885)
Policy (32744)
Tag
Academia (2573)
Alliances (49923)
Alzheimer's disease (1194)
Approvals (16189)
Artificial intelligence (106)
Bankruptcy (356)
Best Places to Work (11465)
Biotechnology (195)
Breast cancer (86)
Cancer (753)
Career advice (1666)
Cell therapy (175)
Clinical research (63831)
Collaboration (260)
Compensation (153)
COVID-19 (2538)
Cystic fibrosis (79)
Data (633)
Diabetes (112)
Diagnostics (6427)
Drug pricing (73)
Earnings (84592)
Employer resources (145)
Events (109660)
Executive appointments (222)
FDA (16643)
Funding (245)
Gene therapy (124)
GLP-1 (543)
Government (4356)
Healthcare (18833)
Infectious disease (2596)
Inflammatory bowel disease (98)
Interviews (309)
IPO (16400)
Job creations (3681)
Job search strategy (1427)
Layoffs (408)
Legal (7898)
Lung cancer (138)
Manufacturing (130)
Medical device (13247)
Medtech (13252)
Mergers & acquisitions (19326)
Metabolic disorders (322)
Neuroscience (1413)
NextGen Class of 2024 (6530)
Non-profit (4516)
Northern California (1053)
Obesity (194)
Opinion (176)
Patents (88)
People (56702)
Phase I (19780)
Phase II (28103)
Phase III (20995)
Pipeline (173)
Postmarket research (2556)
Preclinical (8409)
Radiopharmaceuticals (240)
Rare diseases (163)
Real estate (5978)
Regulatory (21607)
Research institute (2347)
Resumes & cover letters (350)
Southern California (983)
Startups (3641)
United States (10550)
Vaccines (515)
Weight loss (148)
Date
Today (102)
Last 7 days (624)
Last 30 days (2555)
Last 365 days (36609)
2024 (29067)
2023 (40430)
2022 (51549)
2021 (56107)
2020 (54586)
2019 (46975)
2018 (35406)
2017 (32526)
2016 (31989)
2015 (38123)
2014 (31796)
2013 (26921)
2012 (29106)
2011 (29799)
2010 (27788)
Location
Africa (729)
Arizona (184)
Asia (37700)
Australia (6169)
California (2426)
Canada (1106)
China (185)
Colorado (101)
Connecticut (102)
Europe (81329)
Florida (343)
Georgia (89)
Illinois (293)
Indiana (167)
Kansas (96)
Maryland (474)
Massachusetts (1945)
Michigan (136)
Minnesota (247)
New Jersey (727)
New York (742)
North Carolina (667)
Northern California (1053)
Ohio (119)
Pennsylvania (693)
South America (1109)
Southern California (983)
Texas (331)
Utah (71)
Washington State (293)
690,555 Results for "bardy diagnostics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21
Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company has been invited to participate in the Utah booth at the FIME trade show in Miami Beach, Florida, on June 19-21.
June 18, 2024
·
1 min read
Business
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results
Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced financial results for the quarter ended March 31, 2024.
May 9, 2024
·
10 min read
Business
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast
Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first quarter 2024 financial results on Thursday, May 9, 2024, after the market close.
April 25, 2024
·
1 min read
Press Releases
Bracco Diagnostics Inc. and Subtle Medical Announce FDA Clearance of AiMIFY™ Software for Enhanced MRI
October 17, 2024
·
4 min read
News
Co-Diagnostics, Inc. to Host Booth at Medlab Africa in Cape Town on Oct 22-24, 2024
October 21, 2024
·
3 min read
Policy
Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform
Co-Diagnostics, Inc. announced that the Company has completed its first U.S. Food and Drug Administration application for 510 clearance for the Co-Dx™ PCR Pro™ instrument, and the Co-Dx PCR COVID-19 Test for over-the-counter use.
June 14, 2024
·
4 min read
Business
Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results
Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the full year ended December 31, 2023.
March 14, 2024
·
11 min read
Business
Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions
Co-Diagnostics, Inc. today announced that last month the Board of Directors appointed Richard Abbott as President of Co-Diagnostics, Inc., concurrent with the Company naming David Nielsen to be its Chief Operations Officer (COO), Christopher Thurston as its Chief Technology Officer (CTO), and Seth Egan as Chief Commercialization Officer (CCO).
April 4, 2024
·
5 min read
BioMidwest
Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan
Co-Diagnostics, Inc. announced that the Company will be hosting a booth and delivering a presentation at the 9th Asia Pacific Region Conference of the International Union Against Tuberculosis and Lung Disease on April 26-29, 2024 in Taipei, Taiwan.
April 24, 2024
·
2 min read
BioMidwest
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event
Co-Diagnostics, Inc. announced that it held the ribbon cutting event for its new manufacturing facility yesterday in the City of South Salt Lake.
April 12, 2024
·
3 min read
1 of 69,056
Next